13 Tue
All-day
12:00 am
1:00 am
2:00 am
3:00 am
4:00 am
5:00 am
6:00 am
7:00 am
8:00 am
9:00 am
10:00 am
11:00 am
12:00 pm
1:00 pm
2:00 pm
3:00 pm
4:00 pm
5:00 pm
6:00 pm
7:00 pm
8:00 pm
9:00 pm
10:00 pm
11:00 pm
10:20 am Invited Talk: Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease @ Sathyam Hall
Invited Talk: Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease @ Sathyam Hall
Aug 13 @ 10:20 am – 10:40 am
Invited Talk:  Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease @ Sathyam Hall | Vallikavu | Kerala | India
Rajgopal Srinivasan, Ph.D. Principal Scientist & Head Bio IT R&D, TCS Innovation Labs, India Interpretation of Genomic Variation – Identifying Rare Variations Leading to Disease Genome sequencing technologies are generating an abundance of data on human genetic variations. A big challenge
12:13 pm Invited Talk: Regulation of the MHC complex and HLA solubilisation by the Flavivirus, Japanese Encephalitis Virus @ Acharya Hall
Invited Talk: Regulation of the MHC complex and HLA solubilisation by the Flavivirus, Japanese Encephalitis Virus @ Acharya Hall
Aug 13 @ 12:13 pm – 12:40 pm
Invited Talk: Regulation of the MHC complex and HLA solubilisation by the Flavivirus, Japanese Encephalitis Virus @ Acharya Hall | Vallikavu | Kerala | India
R. Manjunath, Ph.D. Associate Professor, Dept of Biochemistry, Indian Institute of Science, Bengaluru, India REGULATION OF THE MHC COMPLEX AND HLA SOLUBILISATION BY THE FLAVIVIRUS, JAPANESE ENCEPHALITIS VIRUS Viral encephalitis caused by Japanese encephalitis virus (JEV) and West Nile Virus
5:06 pm Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall
Aug 13 @ 5:06 pm – 5:27 pm
Invited Talk: New paths for treatment of complex diseases: target combinatorial drug therapy @ Acharya Hall | Vallikavu | Kerala | India
Bodo Eickhoff, Ph.D. Senior Vice-President, Head of Sales and Marketing for Roche Applied Science, Germany New paths for treatment of complex diseases: target combinatorial drug therapy Several types of diseases show a complex pathogenesis and require targeted as well as